PATENT CLAIM ANALYSIS

Application Number: 15750534
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "401000"]

Abstract:
The present invention is directed to a composition comprising from 0.1 to 10.0 wt % of a mixture of glycosaminoglycans comprising dermatan sulfate and chondroitin sulfate, wherein the amount of dermatan sulfate is at least 5% and not more than 95% by weight, and the amount of chondroitin sulfate is at least 5% and not more than 95% by weight, based on the total amount of glycosaminoglycans. Furthermore, the invention is also directed to the use of a glycosaminoglycans composition comprising dermatan sulfate and chondroitin sulfate, wherein the amount of dermatan sulfate is at least 5% and not more than 95% by weight, and the amount of chondroitin sulfate is at least 5% and not more than 95% by weight, based on the total amount of glycosaminoglycans, as an anti-age composition.

Claim (Index 16):
Orally administrable composition comprising the glycosaminoglycans composition according to  claim 12 , wherein the orally administrable composition is substantially free of collagen and elastin.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 88.0
- Lexical Diversity: 3.38636
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13638535', '11638094', '11638318', '13123186', '11078915']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7222154811117184
- 35 USC 102 Novelty (BERT): 0.5116168938358024
- Combined Prediction Score: 0.7011556223841268
- Mean Citation Score: 220.673096
- Max Citation Score: 224.40714
- Similarity Product: 121.4412886254716

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test